GlassScriptPhysician profile
Sukhjeet Singh
NPI 1851690200
$7,166.01
in general payments reported to CMS, 2019-2025
48 companies · $1,600 in 2025
The $1,600 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,042 · 2020: $657 · 2021: $760 · 2022: $1,205 · 2023: $745 · 2024: $1,157 · 2025: $1,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,482 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,481.72 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $977.98 | 2019-2025 | |
| Novo Nordisk INC | $677.38 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $649.51 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $502.02 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $418.88 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $413.23 | 2019-2025 | Farxiga, Lokelma, Breztri |
| Merck Sharp & Dohme LLC | $294.03 | 2021-2025 | Verquvo |
| Pfizer INC. | $292.21 | 2019-2025 | |
| Lilly USA, LLC | $264.97 | 2019-2025 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $264.56 | 2019-2022 | |
| Baxter Healthcare | $202.98 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $188.56 | 2020-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $173.16 | 2021-2025 | |
| Philips North America LLC | $171.72 | 2022-2025 | Mcot, (5044) Mcot |
| Sanofi-Aventis U.S. LLC | $159.44 | 2019-2023 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $137.07 | 2023-2025 | |
| Amgen INC. | $125.76 | 2019-2024 | Tezspire, Repatha |
| Cvrx, INC. | $113.21 | 2024-2025 | Barostim Neo System |
| Boston Scientific Corporation | $108.48 | 2019-2024 | Watchman Flx |
| Actelion Pharmaceuticals US, INC. | $103.74 | 2023-2025 | Opsumit, Opsynvi |
| Esperion Therapeutics, INC. | $99.32 | 2020-2024 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $84.02 | 2021-2025 | Evkeeza |
| Irhythm Technologies, INC. | $66.90 | 2022-2023 | Zio Xt Patch |
| Bridgebio Pharma, INC. | $66.67 | 2025 | Attruby |
| Abbott Laboratories | $55.20 | 2019-2024 | Freestyle Libre 3 |
| Lexicon Pharmaceuticals, INC. | $49.57 | 2023-2024 | Inpefa |
| Glaxosmithkline, LLC. | $47.46 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Impulse Dynamics (USA) INC. | $46.30 | 2025 | Optimizer |
| Corcept Therapeutics | $44.53 | 2025 | Korlym |
| Arbor Pharmaceuticals, INC. | $40.88 | 2021 | |
| Abiomed | $38.88 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $30.46 | 2023 | Arcalyst |
| Lundbeck LLC | $27.77 | 2019-2020 | |
| Bardy Diagnostics, INC. | $25.99 | 2020 | |
| Avadel Cns Pharmaceuticals, LLC | $18.11 | 2025 | Lumryz |
| Hologic Sales and Service, LLC | $16.66 | 2019 | |
| Exact Sciences Corporation | $16.58 | 2025 | Cologuard Collection Kit |
| Chiesi USA, INC. | $15.52 | 2024 | Juxtapid |
| Alnylam Pharmaceuticals INC. | $15.10 | 2019 | |
| Celgene Corporation | $14.74 | 2019 | |
| Genzyme Corporation | $14.64 | 2019 | |
| Atricure, INC. | $14.51 | 2025 | Atriclip Laa Exclusion System |
| Heartflow, INC. | $14.29 | 2022 | |
| Horizon Therapeutics Plc | $13.90 | 2019 | |
| Althera Pharmaceuticals LLC | $13.89 | 2022 | |
| Abbvie INC. | $12.91 | 2020 | |
| Vivus LLC | $12.00 | 2019 | |
| Cashflow Solutions, LLC | $10.32 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sukhjeet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.